A Randomized Study of Paclitaxel – Carboplatin followed by maintenance Niraparib compared to Paclitaxel – Carboplatin – Bevacizumab followed by maintenance Niraparib + Bevacizumab in Patients With Advanced Ovarian Cancer, Following a Front-Line Complete Cytoreductive Surgery
Trial Number
NCT05183984 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
GEICO
MaNGO
BGOG
GOTIC
KGOG